{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:26:18Z","timestamp":1792531578879,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"SI","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100008604","name":"Scleroderma and Raynaud\u2019s UK","doi-asserted-by":"crossref","award":["RBH1"],"award-info":[{"award-number":["RBH1"]}],"id":[{"id":"10.13039\/501100008604","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Interstitial lung disease (ILD) is the most common cause of death in patients with systemic sclerosis (SSc), although disease behaviour is highly heterogeneous. While a usual interstitial pneumonia (UIP) pattern is associated with worse survival in other ILDs, its significance in SSc-ILD is unclear. We sought to assess the prognostic utility of a deep-learning high resolution CT (HRCT) algorithm of UIP probability in SSc-ILD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with SSc-ILD were included if HRCT images, concomitant lung function tests and follow-up data were available. We used the Systematic Objective Fibrotic Imaging analysis Algorithm (SOFIA), a convolution neural network algorithm that provides probabilities of a UIP pattern on HRCT images. These were converted into the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)-based UIP probability categories. Decline in lung function was assessed by mixed-effect model analysis and relationship with survival by Cox proportional hazards analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five hundred and twenty-two patients were included in the study; 19.5% were classified as UIP not in the differential, 53.5% as low probability of UIP, 25.7% as intermediate probability of UIP, and 1.3% as high probability of UIP. A higher likelihood of UIP probability expressed as PIOPED categories was associated with worse baseline forced vital capacity (FVC), as well as with decline in FVC (P\u2009=\u20090.008), and worse 15-year survival (P\u2009=\u20090.001), both independently of age, gender, ethnicity, smoking history and baseline FVC or Goh et al. staging system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A higher probability of a SOFIA-determined UIP pattern is associated with more advanced ILD, disease progression and worse survival, suggesting that it may be a useful prognostic marker in SSc-ILD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae571","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T15:31:51Z","timestamp":1729006311000},"page":"SI21-SI27","source":"Crossref","is-referenced-by-count":17,"title":["Deep-learning CT imaging algorithm to detect usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease: association with disease progression and survival"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4090-8761","authenticated-orcid":false,"given":"Carmel J W","family":"Stock","sequence":"first","affiliation":[{"name":"Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London,","place":["UK"]},{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Nan","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Fang","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kokosi","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London,","place":["UK"]},{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Kouranos","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London,","place":["UK"]},{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"George","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London,","place":["UK"]},{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Chua","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London,","place":["UK"]},{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisli R","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London,","place":["UK"]},{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Devaraj","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , London,","place":["UK"]},{"name":"Department of Radiology, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujal R","family":"Desai","sequence":"additional","affiliation":[{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London , London,","place":["UK"]},{"name":"Department of Radiology, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3975-8938","authenticated-orcid":false,"given":"Christopher P","family":"Denton","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology, Division of Medicine, UCL , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athol U","family":"Wells","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London,","place":["UK"]},{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon L F","family":"Walsh","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , London,","place":["UK"]},{"name":"Department of Radiology, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta A","family":"Renzoni","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London,","place":["UK"]},{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"2025121017320270900_keae571-B1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025121017320270900_keae571-B2","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(21)01961-9","article-title":"Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?","volume":"398","author":"Renzoni","year":"2021","journal-title":"Lancet"},{"key":"2025121017320270900_keae571-B3","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2025121017320270900_keae571-B4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12890-019-0943-2","article-title":"Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study","volume":"19","author":"Chan","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2025121017320270900_keae571-B5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.resinv.2016.05.004","article-title":"A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease","volume":"54","author":"Okamoto","year":"2016","journal-title":"Respir Investig"},{"key":"2025121017320270900_keae571-B6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/resp.13175","article-title":"Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease","volume":"23","author":"Takei","year":"2018","journal-title":"Respirology"},{"key":"2025121017320270900_keae571-B7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2213-2600(18)30286-8","article-title":"Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study","volume":"6","author":"Walsh","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2025121017320270900_keae571-B8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1164\/rccm.202112-2684OC","article-title":"Deep learning-based outcome prediction in progressive fibrotic lung disease using high-resolution computed tomography","volume":"206","author":"Walsh","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2025121017320270900_keae571-B9","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1378\/chest.10-2545","article-title":"Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis","volume":"140","author":"Rosas","year":"2011","journal-title":"Chest"},{"key":"2025121017320270900_keae571-B10","doi-asserted-by":"crossref","first-page":"1601011","DOI":"10.1183\/13993003.01011-2016","article-title":"Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures","volume":"49","author":"Jacob","year":"2017","journal-title":"Eur Respir J"},{"key":"2025121017320270900_keae571-B11","doi-asserted-by":"crossref","first-page":"1802341","DOI":"10.1183\/13993003.02341-2018","article-title":"Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis","volume":"54","author":"Jacob","year":"2019","journal-title":"Eur Respir J"},{"key":"2025121017320270900_keae571-B12","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1093\/rheumatology\/keac184","article-title":"Automated quantification system predicts survival in rheumatoid arthritis-associated interstitial lung disease","volume":"61","author":"Oh","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025121017320270900_keae571-B13","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025121017320270900_keae571-B14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2025121017320270900_keae571-B15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2025121017320270900_keae571-B16","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1001\/jama.1990.03440200057023","article-title":"Value of the ventilation\/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED)","volume":"263","author":"Investigators","year":"1990","journal-title":"JAMA"},{"key":"2025121017320270900_keae571-B17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1536867X0200200401","article-title":"Using Aalen\u2019s Linear Hazards Model to Investigate Time-varying Effects in the Proportional Hazards Regression Model","volume":"2","author":"Hosmer","year":"2002","journal-title":"The Stata Journal"},{"key":"2025121017320270900_keae571-B18","volume-title":"An introduction to survival analysis using stata","author":"Mario Cleves","year":"2016","edition":"Revised 3rd ed."},{"key":"2025121017320270900_keae571-B19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.07-2444","article-title":"High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease","volume":"134","author":"Goldin","year":"2008","journal-title":"Chest"},{"key":"2025121017320270900_keae571-B20","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S2213-2600(20)30003-5","article-title":"Imaging research in fibrotic lung disease; applying deep learning to unsolved problems","volume":"8","author":"Walsh","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025121017320270900_keae571-B21","first-page":"1596","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease. Reply","volume":"381","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"2025121017320270900_keae571-B22","doi-asserted-by":"crossref","first-page":"104062","DOI":"10.1016\/j.lpm.2021.104062","article-title":"Pulmonary arterial hypertension in systemic sclerosis","volume":"50","author":"Lechartier","year":"2021","journal-title":"Presse Med"},{"key":"2025121017320270900_keae571-B23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s42358-022-00239-2","article-title":"Increased risk of mortality in systemic sclerosis-associated pulmonary hypertension: a systemic review and meta-analysis","volume":"62","author":"Xiong","year":"2022","journal-title":"Adv Rheumatol"},{"key":"2025121017320270900_keae571-B24","doi-asserted-by":"crossref","first-page":"103290","DOI":"10.1016\/j.autrev.2023.103290","article-title":"The role of TAPSE\/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort","volume":"22","author":"Colalillo","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2025121017320270900_keae571-B25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.41512","article-title":"Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease","volume":"73","author":"Chauvelot","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025121017320270900_keae571-B26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1148\/radiol.2471070369","article-title":"Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time","volume":"247","author":"Silva","year":"2008","journal-title":"Radiology"},{"key":"2025121017320270900_keae571-B27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12890-020-1061-x","article-title":"Impact of radiological honeycombing in rheumatoid arthritis-associated interstitial lung disease","volume":"20","author":"Yamakawa","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2025121017320270900_keae571-B28","first-page":"1670","article-title":"Usual interstitial pneumonia is the predominant histopathology in patients with systemic sclerosis receiving a lung transplant","volume":"41","author":"Valenzi","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"2025121017320270900_keae571-B29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S2213-2600(22)00475-1","article-title":"Usual interstitial pneumonia as a stand-alone diagnostic entity: the case for a paradigm shift?","volume":"11","author":"Selman","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2025121017320270900_keae571-B30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","article-title":"Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy","volume":"134","author":"Selman","year":"2001","journal-title":"Ann Intern Med"},{"key":"2025121017320270900_keae571-B31","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s00330-021-08378-8","article-title":"Radiologic-pathologic correlation of interstitial lung abnormalities and predictors for progression and survival","volume":"32","author":"Chae","year":"2022","journal-title":"Eur Radiol"},{"key":"2025121017320270900_keae571-B32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1513\/AnnalsATS.202305-402OC","article-title":"The impact of occupational exposures on the risk of idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"21","author":"Gandhi","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"2025121017320270900_keae571-B33","first-page":"1933","article-title":"Early pulmonary involvement in systemic sclerosis assessed by technetium-99m-DTPA clearance rate","volume":"35","author":"Fanti","year":"1994","journal-title":"J Nucl Med"},{"key":"2025121017320270900_keae571-B34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3899\/jrheum.170518","article-title":"KL-6 but not CCL-18 is a predictor of early progression in systemic sclerosis-related interstitial lung disease","volume":"45","author":"Salazar","year":"2018","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae571\/60415307\/keae571.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/SI\/SI21\/60415307\/keae571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/SI\/SI21\/60415307\/keae571.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T22:32:16Z","timestamp":1765405936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/SI\/SI21\/7825351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":34,"journal-issue":{"issue":"SI","published-online":{"date-parts":[[2024,10,17]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae571","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2024,10,17]]}}}